Stocktoria
National Vision Holdings, Inc. EYE
Nasdaq · XNAS · stock · Ophthalmic Goods · website · IPO 2017-10-26
National Vision Holdings, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2026 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Operating margin | 3.0% | -0.6% | 1.4% | 3.2% | 8.4% |
| Net margin | 1.5% | -1.6% | -3.8% | 2.6% | 6.2% |
| FCF margin | 3.7% | 2.1% | 3.3% | 0.3% | 7.9% |
| Return on assets | 1.5% | -1.4% | -3.0% | 1.8% | 5.6% |
| Return on equity | 3.4% | -3.5% | -7.9% | 4.7% | 13.8% |
| Debt / equity | 0.27× | 0.41× | 0.54× | 0.61× | 0.59× |
| Current ratio | 0.55 | 0.53 | 1.00 | 1.38 | 1.50 |
| Revenue growth | 9.0% | 3.8% | 6.8% | -20.9% | 21.5% |
Source: SEC EDGAR filings · CIK 0001710155 · as of 2026-01-03. Facts from filings plus Stocktoria's own computed scores — not investment advice.